68 related articles for article (PubMed ID: 1355999)
1. Adjuvant chemotherapy for breast cancer. NIH consensus development conference, September 9-11, 1985.
Cancer Treat Res; 1992; 60():375-82. PubMed ID: 1355999
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy of breast cancer. NIH consensus development conference, July 14-16, 1980.
Cancer Treat Res; 1992; 60():371-4. PubMed ID: 1355998
[No Abstract] [Full Text] [Related]
3. [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].
Ikeda T; Jinno H; Masamura S; Matsui A; Tajima G; Hohjoh T; Tokura H; Mitsui Y; Asaga S; Muto T; Fujiwara K; Kitajima M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):902-8. PubMed ID: 11478138
[TBL] [Abstract][Full Text] [Related]
4. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
[No Abstract] [Full Text] [Related]
5. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.
Lippman ME; Chabner BA
NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591
[No Abstract] [Full Text] [Related]
9. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
[No Abstract] [Full Text] [Related]
10. Adjuvant chemotherapy of early breast cancer.
Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039
[No Abstract] [Full Text] [Related]
11. Current status of post-chemotherapy tamoxifen in early breast cancer.
Tolcher AW
Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
[TBL] [Abstract][Full Text] [Related]
12. Consensus statement outlines adjuvant treatment options for women with breast cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2001 Jan; 12(2):9-10, 12. PubMed ID: 11767779
[No Abstract] [Full Text] [Related]
13. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
Eur J Cancer; 1992; 28A(4-5):904-7. PubMed ID: 1524921
[TBL] [Abstract][Full Text] [Related]
14. [Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases].
Roy JA; Piccart MJ
Rev Med Brux; 1995; 16(4):242-4. PubMed ID: 7481234
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment.
Kourounis G; Zervoudis S; Michail G; Fotopoulos A
Breast J; 2005; 11(5):365-6. PubMed ID: 16174165
[No Abstract] [Full Text] [Related]
16. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
Chrapusta SJ; Giermek J; Pieńkowski T
Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant tamoxifen and chemotherapy prolongs life and increases disease-free survival of women with breast cancer.
Oncology (Williston Park); 1992 Jan; 6(1):86. PubMed ID: 1531606
[No Abstract] [Full Text] [Related]
18. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
